Allergies News and Research

Latest Allergies News and Research

Study shows how D614G variant gains upper hand over original SARS-CoV-2 virus

Prior to the emergence of new mutants of the coronavirus, such as the British variant B.1.1.7, the SARS-CoV-2 variant named D614G had already mutated from the original SARS-CoV-2 pathogen that triggered the pandemic.

27 Feb 2021

Diverse patient population helps identify gene variant associated with childhood asthma

Researchers at Henry Ford Health System, as part of a national asthma collaborative, have identified a gene variant associated with childhood asthma that underscores the importance of including diverse patient populations in research studies.

27 Feb 2021

Researchers investigate the duration of the immune response to SARS-CoV-2

The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new Penn State-led study.

26 Feb 2021

Study explains the evolution of SARS-CoV-2 virus

As COVID-19 sweeps the world, related viruses quietly circulate among wild animals. A new study shows how SARS-CoV-2, the virus that causes COVID-19, and SARS-CoV-1, which caused the 2003 SARS outbreak, are related to each other.

26 Feb 2021

Changes to infant feeding guidelines have led to a decrease in peanut allergy

Changes to food allergy guidelines have led to a 16 per cent decrease in peanut allergy among infants, according to new study.

25 Feb 2021

Researchers identify 'violent' physical processes which cause wheezing

A team of engineers has identified the 'violent' physical processes at work inside the lungs which cause wheezing, a condition which affects up to a quarter of the world's population.

24 Feb 2021

Beneficial bacteria passed on to infants through breast milk change over time

The cocktail of beneficial bacteria passed from mother to infant through breast milk changes significantly over time and could act like a daily booster shot for infant immunity and metabolism.

23 Feb 2021

Phase 1 clinical trial shows promising results for monoclonal antibodies against MERS coronavirus

A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed against the coronavirus that causes Middle East respiratory syndrome (MERS) found that they were well tolerated and generally safe when administered simultaneously to healthy adults.

23 Feb 2021

Study reveals new routes to potential treatments for chronic inflammatory conditions

Inflammatory lung diseases such as asthma, COPD and, most recently, COVID-19, have proven difficult to treat.

23 Feb 2021

'Phage therapy' helps treat mice infected with multidrug-resistant Klebsiella pneumoniae

Using viruses instead of antibiotics to tame troublesome drug-resistant bacteria is a promising strategy, known as bacteriophage or "phage therapy."

23 Feb 2021

Researchers develop a mathematical means of assessing COVID-19 tests' false-negative rate

Even with more than 1.5 million Americans receiving a COVID vaccine each day, officials estimate it will take many more months before enough people are protected from the deadly virus.

22 Feb 2021

Children exposed to air pollution may be at higher risk of disease in adulthood

Children exposed to air pollution, such as wildfire smoke and car exhaust, for as little as one day may be doomed to higher rates of heart disease and other ailments in adulthood, according to a new Stanford-led study.

22 Feb 2021

Study provides new information about the structure of prion proteins

Prion diseases are a group of rapidly progressive, fatal and infectious neurodegenerative disorders affecting both humans and animals: Bovine Spongiform Encephalopathy (BSE) or 'mad cow' disease is one of the most famous since in 1996 scientists found that the agent responsible for the disease in cows, is the same agent responsible for the so-called variant Creutzfeldt-Jakob Disease (vCJD), a disease affecting humans.

20 Feb 2021

Whole-genome study of IBD in African Americans reveals a different genetic risk landscape

In African Americans, the genetic risk landscape for inflammatory bowel disease (IBD) is very different from that of people with European ancestry, according to results of the first whole-genome study of IBD in African Americans.

20 Feb 2021

Experts advocate for increased diversity in vaccine clinical trials

A team of scientific experts from across the U.S. and Puerto Rico are advocating for increased diversity in vaccine trials after publishing a new report that highlights a decade's worth of disparities.

20 Feb 2021

Study: First influenza infection does not make people immune to future flu viruses

A child's first influenza infection shapes their immunity to future airborne flu viruses-;including emerging pandemic strains.

19 Feb 2021

Cone snail venom could potentially treat severe forms of malaria

Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.

18 Feb 2021

‘I wanted to go in there and help’: Nursing schools see enrollment bump amid pandemic

Last December, Mirande Gross graduated from Bellarmine University in Louisville, Kentucky, with a bachelor's degree in communications.

18 Feb 2021

Sensor-based asthma inhalers can benefit pediatric asthma patients

Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.

17 Feb 2021

Pan-coronavirus vaccine needed to deal SARS-CoV-2 variants

In an article, published on the JAMA Network and written by health experts, including Dr. Anthony Fauci, American physician-scientist and immunologist serving as the director of the National Institute of Allergy and Infectious Diseases, the authors discuss the need for a pan-coronavirus vaccine, which can protect against most or all variants of SARS-CoV-2.

16 Feb 2021

Allergies News and Research

Latest Allergies News and Research

Study shows how D614G variant gains upper hand over original SARS-CoV-2 virus

Diverse patient population helps identify gene variant associated with childhood asthma

Researchers investigate the duration of the immune response to SARS-CoV-2

Study explains the evolution of SARS-CoV-2 virus

Changes to infant feeding guidelines have led to a decrease in peanut allergy

Researchers identify 'violent' physical processes which cause wheezing

Beneficial bacteria passed on to infants through breast milk change over time

Phase 1 clinical trial shows promising results for monoclonal antibodies against MERS coronavirus

Study reveals new routes to potential treatments for chronic inflammatory conditions

'Phage therapy' helps treat mice infected with multidrug-resistant Klebsiella pneumoniae

Researchers develop a mathematical means of assessing COVID-19 tests' false-negative rate

Children exposed to air pollution may be at higher risk of disease in adulthood

Study provides new information about the structure of prion proteins

Whole-genome study of IBD in African Americans reveals a different genetic risk landscape

Experts advocate for increased diversity in vaccine clinical trials

Study: First influenza infection does not make people immune to future flu viruses

Cone snail venom could potentially treat severe forms of malaria

‘I wanted to go in there and help’: Nursing schools see enrollment bump amid pandemic

Sensor-based asthma inhalers can benefit pediatric asthma patients

Pan-coronavirus vaccine needed to deal SARS-CoV-2 variants

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in